Meet us at SEMES Emergency Conference in Toledo, Spain and hear about suPARnostic®!

 

ViroGates publishes prospectus for its initial public offering in Copenhagen.

ViroGates intends to strengthen its capital structure to intensify the continued commercial roll-out of its products and strengthen its product development, clinical documentation and global patent coverage.